南华生物 (000504.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(南华生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 34,326,150.5435,694,129.9234,739,572.6843,940,880.7246,627,374.1944,958,566.2164,818,635.90
 营业收入(元) 34,326,150.5435,694,129.9234,739,572.6843,940,880.7246,627,374.1944,958,566.2164,818,635.90
二、营业总成本(元) 37,424,774.5739,953,208.2835,814,358.2754,844,765.6042,100,442.4342,974,928.2567,346,075.15
 营业成本(元) 10,654,576.7312,843,622.0010,871,092.369,784,388.0711,080,725.2614,169,123.1535,503,848.85
 研发费用(元) 2,578,584.092,162,860.032,197,527.493,089,740.102,555,659.812,488,673.601,851,153.17
 营业税金及附加(元) 285,328.71281,845.30213,636.09344,826.05322,634.85272,536.49182,267.06
 销售费用(元) 9,272,960.279,679,962.758,743,639.4823,682,997.1312,030,602.7211,402,532.3313,314,914.91
 管理费用(元) 12,265,176.9412,488,401.6011,823,853.1615,407,700.7013,712,379.1011,635,458.4612,847,544.75
 财务费用(元) 2,368,147.832,496,516.601,964,609.692,535,113.552,398,440.693,006,604.223,646,346.41
  其中:利息费用(元) 2,445,744.362,465,152.212,740,409.021,900,730.653,239,989.392,817,951.213,909,140.86
  其中:利息收入(元) 307,448.19517,324.69874,563.76465,582.05430,497.01480,479.09400,415.62
 资产减值损失(元) ----2,382,190.01263,400.05--
 信用减值损失(元) ----25,200,403.5911,715.00--
三、其他经营收益
 加:公允价值变动收益(元) -131,532.15-66,687.80-15,609.37343,035.11-111,669.7463,187.48-353,437.32
 加:投资收益(元) 210,690.17361,819.62214,734.95145,408.72130,959.744,839.07-277,352.10
  其中:对联营企业和合营企业的投资收益(元) ----395,423.25---
 资产处置收益(元) 13,820,617.47--10,320.92-16.97--
 其他收益(元) 469,763.18217,406.87709,419.533,449,252.431,806,174.121,679,782.81597,274.96
四、营业利润(元) 11,270,914.64-6,238,962.85-166,240.48-34,538,461.306,627,493.964,322,577.00-2,560,953.71
 加:营业外收入(元) 5,398.23912.171,000,000.00-20,620.4013,681.884,523,108.88116,127.27
 减:营业外支出(元) 689.53-1,199.007,500.3618,676.409,590.836,602.42
五、利润总额(元) 11,275,623.34-6,238,050.68832,560.52-34,566,582.066,622,499.448,836,095.05-2,451,428.86
 减:所得税费用(元) 744,973.2521,231.12394,692.413,354,749.362,339,297.581,721,852.45786,104.43
六、净利润(元) 10,530,650.09-6,259,281.80437,868.11-37,921,331.424,283,201.867,114,242.60-3,237,533.29
(一)按经营持续性分类
  持续经营净利润(元) 10,530,650.09-6,259,281.80437,868.11-37,921,331.424,283,201.867,114,242.60-3,237,533.29
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 9,459,873.30-6,997,109.89-1,976,045.11-13,235,497.44-1,626,202.672,007,019.74159,904.25
  少数股东损益(元) 1,070,776.79737,828.092,413,913.22-24,685,833.985,909,404.535,107,222.86-3,397,437.54
 扣除非经常性损益后的净利润(元) -4,634,261.47-7,355,635.07-3,491,368.05-16,837,898.53-2,053,971.18-4,058,084.08-100,474.77
七、每股收益
 一、基本每股收益(元) 0.03-0.02-0.01-0.04-0.010.01-
 二、稀释每股收益(元) 0.03-0.02-0.01-0.04-0.010.01-
九、综合收益总额(元) 10,530,650.09-6,259,281.80437,868.11-37,921,331.424,283,201.867,114,242.60-3,237,533.29
 归属于母公司所有者的综合收益总额(元) 9,459,873.30-6,997,109.89-1,976,045.11-13,235,497.44-1,626,202.672,007,019.74159,904.25
 归属于少数股东的综合收益总额(元) 1,070,776.79737,828.092,413,913.22-24,685,833.985,909,404.535,107,222.86-3,397,437.54
公告日期 2023-10-312023-08-302023-04-292023-04-212022-10-312022-07-302022-04-30
审计意见(境内) 标准无保留意见

前瞻产业研究院